Skip to main content
. 2019 Jun 26;9:225. doi: 10.3389/fcimb.2019.00225

Figure 1.

Figure 1

CEH combined with CDDP chemotherapy inhibits the growth of ESCC in vivo. (A) The timeline for ESCC xenografts mouse model construction and chemotherapy strategy. (B) Time courses of animal body weight. (C) Time courses of xenograft tumor volume. (D) Xenograft tumor weight histogram. (E) Tumor inhibition rate of CEH, CDDP, and combination chemotherapy strategies. (F) TUNEL staining of paraffin sections of xenograft tumor tissues. Error bars represent mean ± SD. N, negative control; M, model control; CDDP, CDDP chemotherapy; CEH, cepharanthine hydrochloride chemotherapy; Comb, combined chemotherapy strategy; ns, no significant difference. *P < 0.05, **P < 0.01, ***P < 0.001.